# Hurco Companies Inc: overview HURC · Nasdaq · CIK 315374 · [Technology](/sectors/technology.md) · fiscal year ends Oct 31 Pages: [Overview](/companies/hurc.md) · [Financials](/companies/hurc/financials.md) · [Filings](/companies/hurc/filings.md) · [Insiders](/companies/hurc/insiders.md) Latest reported revenue: [$47.3m](/filings/0001104659-26-105453.md) for Q3 FY2026, three months to 2026-07-31, from the 10-Q filed Sep 4, 2026 (XBRL us-gaap:Revenues, accession 0001104659-26-105453). ## Last eight quarters | Line item | Unit | Q4 FY2024 (2024-10-31) | Q1 FY2025 (2025-01-31) | Q2 FY2025 (2025-04-30) | Q3 FY2025 (2025-07-31) | Q4 FY2025 (2025-10-31) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-04-30) | Q3 FY2026 (2026-07-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [53.7 d](/filings/0001104659-26-002512.md) | [46.4](/filings/0001104659-26-024614.md) | [40.9](/filings/0001104659-26-070920.md) | [45.8](/filings/0001104659-26-105453.md) | [45.5 d](/filings/0001104659-26-002512.md) | [42.9](/filings/0001104659-26-024614.md) | [47.6](/filings/0001104659-26-070920.md) | [47.3](/filings/0001104659-26-105453.md) | | Gross margin | % | [22.7% d](/filings/0001104659-26-002512.md) | [17.9%](/filings/0001104659-26-024614.md) | [19.2%](/filings/0001104659-26-070920.md) | [19.9%](/filings/0001104659-26-105453.md) | [17.0% d](/filings/0001104659-26-002512.md) | [18.5%](/filings/0001104659-26-024614.md) | [21.7%](/filings/0001104659-26-070920.md) | [27.9%](/filings/0001104659-26-105453.md) | | Operating margin | % | [(0.9%) d](/filings/0001104659-26-002512.md) | [(4.5%)](/filings/0001104659-26-024614.md) | [(7.5%)](/filings/0001104659-26-070920.md) | [(3.6%)](/filings/0001104659-26-105453.md) | [(7.6%) d](/filings/0001104659-26-002512.md) | [(7.4%)](/filings/0001104659-26-024614.md) | [(1.7%)](/filings/0001104659-26-070920.md) | [4.9%](/filings/0001104659-26-105453.md) | | Net margin | % | [(2.7%) d](/filings/0001104659-26-002512.md) | [(9.3%)](/filings/0001104659-26-024614.md) | [(9.9%)](/filings/0001104659-26-070920.md) | [(8.1%)](/filings/0001104659-26-105453.md) | [(6.7%) d](/filings/0001104659-26-002512.md) | [(8.1%)](/filings/0001104659-26-024614.md) | [(5.0%)](/filings/0001104659-26-070920.md) | [4.9%](/filings/0001104659-26-105453.md) | | Diluted EPS | $ per share | not reported | [(0.67)](/filings/0001104659-26-024614.md) | [(0.62)](/filings/0001104659-26-070920.md) | [(0.58)](/filings/0001104659-26-105453.md) | not reported | [(0.54)](/filings/0001104659-26-024614.md) | [(0.37)](/filings/0001104659-26-070920.md) | [0.35](/filings/0001104659-26-105453.md) | | Free cash flow | $m | [(1.7) d](/filings/0001104659-26-002512.md) | [10.2](/filings/0001104659-26-024614.md) | [0.7](/filings/0001104659-26-070920.md) | [2.1](/filings/0001104659-26-105453.md) | [3.7 d](/filings/0001104659-26-002512.md) | [(0.7)](/filings/0001104659-26-024614.md) | [2.0](/filings/0001104659-26-070920.md) | [3.5](/filings/0001104659-26-105453.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-10-31) | FY2022 (2022-10-31) | FY2023 (2023-10-31) | FY2024 (2024-10-31) | FY2025 (2025-10-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [235](/filings/0001558370-24-000115.md) | [251](/filings/0001558370-25-000129.md) | [228](/filings/0001104659-26-002512.md) | [187](/filings/0001104659-26-002512.md) | [179](/filings/0001104659-26-002512.md) | | Gross margin | % | [23.9%](/filings/0001558370-24-000115.md) | [25.7%](/filings/0001558370-25-000129.md) | [24.7%](/filings/0001104659-26-002512.md) | [20.2%](/filings/0001104659-26-002512.md) | [18.5%](/filings/0001104659-26-002512.md) | | Operating margin | % | [4.4%](/filings/0001558370-24-000115.md) | [5.1%](/filings/0001558370-25-000129.md) | [2.9%](/filings/0001104659-26-002512.md) | [(4.4%)](/filings/0001104659-26-002512.md) | [(5.8%)](/filings/0001104659-26-002512.md) | | Net margin | % | [2.9%](/filings/0001558370-24-000115.md) | [3.3%](/filings/0001558370-25-000129.md) | [1.9%](/filings/0001104659-26-002512.md) | [(8.9%)](/filings/0001104659-26-002512.md) | [(8.5%)](/filings/0001104659-26-002512.md) | | Diluted EPS | $ per share | [1.01](/filings/0001558370-24-000115.md) | [1.23](/filings/0001558370-25-000129.md) | [0.66](/filings/0001104659-26-002512.md) | [(2.56)](/filings/0001104659-26-002512.md) | [(2.34)](/filings/0001104659-26-002512.md) | | Free cash flow | $m | [30.9](/filings/0001558370-24-000115.md) | [(5.1)](/filings/0001558370-25-000129.md) | [(14.1)](/filings/0001104659-26-002512.md) | [(3.8)](/filings/0001104659-26-002512.md) | [16.7](/filings/0001104659-26-002512.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/hurc/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Oppenheimer & Close, LLC](/funds/1591377.md) | 2026-06-30 | $10.5m | 460,214 | | Added +3,034 | | [BRANDES INVESTMENT PARTNERS, LP](/funds/1015079.md) | 2026-06-30 | $9.6m | 417,517 | | Reduced −173,889 | | [Brooklands Fund Management Ltd](/funds/2036388.md) | 2026-06-30 | $7.8m | 354,068 | | Unchanged | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $7.2m | 316,214 | | Reduced −30,524 | | [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $7.0m | 305,234 | | Added +34,200 | | [Peapod Lane Capital LLC](/funds/2050979.md) | 2026-06-30 | $6.1m | 264,792 | | Added +19,924 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $6.0m | 259,917 | | Added +4,797 | | [Meros Investment Management, LP](/funds/1911372.md) | 2026-06-30 | $4.8m | 211,318 | | Reduced −221 | | [IFP Advisors, Inc](/funds/1641866.md) | 2026-06-30 | $4.6m | 200,068 | | Unchanged | | [Pacific Ridge Capital Partners, LLC](/funds/1591546.md) | 2026-06-30 | $3.9m | 169,747 | | Reduced −1,314 | ## Recent filings [All 690 filings](/companies/hurc/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-04 | 14:38 ET | [10-Q](/filings/0001104659-26-105453.md) | Quarterly report, period 2026-07-31 | 0001104659-26-105453 | | 2026-09-04 | 10:31 ET | [8-K](/filings/0001104659-26-105339.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-105339 | | 2026-06-05 | 14:44 ET | [10-Q](/filings/0001104659-26-070920.md) | Quarterly report, period 2026-04-30 | 0001104659-26-070920 | | 2026-06-05 | 10:36 ET | [8-K](/filings/0001104659-26-070810.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-070810 | | 2026-03-16 | 16:37 ET | [8-K](/filings/0001104659-26-028523.md) | 5.07 Shareholder vote results | 0001104659-26-028523 | | 2026-03-06 | 14:26 ET | [10-Q](/filings/0001104659-26-024614.md) | Quarterly report, period 2026-01-31 | 0001104659-26-024614 | | 2026-03-06 | 08:19 ET | [8-K](/filings/0001104659-26-024429.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-024429 | | 2026-01-28 | 08:48 ET | [DEF 14A](/filings/0001104659-26-007238.md) | Proxy statement, period 2026-03-12 | 0001104659-26-007238 | | 2026-01-09 | 16:42 ET | [10-K](/filings/0001104659-26-002512.md) | Annual report, period 2025-10-31 | 0001104659-26-002512 | | 2026-01-09 | 10:56 ET | [8-K](/filings/0001104659-26-002361.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-002361 | ## Latest annual report [Form 10-K for the fiscal year ended Oct 31, 2025](/filings/0001104659-26-002512.md), filed Jan 9, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 315374 - Tickers: HURC - Exchange: Nasdaq - SIC code: 3823 Industrial Instruments For Measurement, Display, and Control - State of incorporation: IN - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.